CRYOPORT, INC. (NASDAQ:CYRX) Files An 8-K Changes in Registrant’s Certifying Accountant
Item 4.01
The Company has provided KMJ with the disclosures under this Item 4.01(a), and has requested KMJ to furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether it agrees with the statements made by the Company in this Item 4.01(a) and, if not, stating the respects in which it does not agree. KMJ’s letter is filed as Exhibit 16.1 to this Current Report on Form 8-K.
| Letter to Securities and Exchange Commission from KMJ Corbin & Company LLP dated August 16, 2019 |
Cryoport, Inc. Exhibit
EX-16.1 2 tv527985_ex16-1.htm EXHIBIT 16.1 Exhibit 16.1 August 16,…
To view the full exhibit click here
About CRYOPORT, INC. (NASDAQ:CYRX)
Cryoport, Inc. (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients. The Company’s Cryoport Express Solution includes a cloud-based logistics operating platform, which is branded as the Cryoportal. The Company’s Cryoport Express Solutions are made up of the Cryoportal software platform, Cryoport Express Shippers, Cryoport Express Smart Pak data loggers and its life sciences cold chain logistics expertise. The Cryoportal is used by the Company, its clients and its business partners to automate the entry of orders, prepare customs documentation, and to facilitate status and location monitoring of shipped orders while in transit.
